Saltar al contenido
MilliporeSigma

Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.

Chemosphere (2014-07-30)
Gracia Márquez, Eva M Rodríguez, Fernando J Beltrán, Pedro M Álvarez
RESUMEN

Aqueous solutions of mixtures of four pharmaceutical compounds (atenolol, hydrochlorothiazide, ofloxacin and trimethoprim) both in Milli-Q ultrapure water and in a secondary effluent from a municipal wastewater treatment plant have been treated at pH 7 by different oxidation methods, such as conventional ozonation, photolytic ozonation, TiO2 catalytic ozonation, TiO2 photocatalytic oxidation and TiO2 photocatalytic ozonation. Experiments were carried out using a solar compound parabolic concentrator. The performance results have been compared in terms of removal of emerging contaminants (ECs), generation rate of phenolic intermediates, organic matter mineralization, ecotoxicity removal and enhancement of biodegradability. Also, the consumption of ozone to achieve certain treatment goals (95% removal of ECs and 40% mineralization) is discussed. Results reveal that solar photocatalytic ozonation is a promising oxidation method as it led to the best results in terms of EC mineralization (∼85%), toxicity removal (∼90%) and efficient use of ozone (∼2mgO3mgEC(-1) to achieve complete EC removal and ∼18mgO3mgTOC(-1) to achieve 40% EC mineralization, respectively).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Óxido de titanio (IV), nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
Titanium(IV) oxide, anatase, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
Trimetoprim, ≥98.5%
Sigma-Aldrich
Óxido de titanio (IV), puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
Sigma-Aldrich
Titanium(IV) oxide, anatase, powder, 99.8% trace metals basis
Sigma-Aldrich
Óxido de titanio (IV), ReagentPlus®, ≥99%
Sigma-Aldrich
Titanium(IV) oxide, rutile, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Titanium(IV) oxide, anatase, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
Titanium(IV) oxide, rutile, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
Trimetoprim, ≥99.0% (HPLC)
Sigma-Aldrich
Titanium(IV) oxide, mixture of rutile and anatase, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Titanium, foil, thickness 0.127 mm, 99.7% trace metals basis
Sigma-Aldrich
Titanium, powder, <45 μm avg. part. size, 99.98% trace metals basis
Sigma-Aldrich
Titanium, foil, thickness 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
Titanium, powder, −100 mesh, 99.7% trace metals basis
USP
Hydrochlorothiazide, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Titanium(IV) oxide, rutile, ≥99.98% trace metals basis
Supelco
Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Titanium(IV) oxide, rutile, 99.995% trace metals basis
Sigma-Aldrich
Óxido de titanio (IV), contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Titanium, wire, diam. 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
Titanium, sponge, 1-20 mm, 99.5% trace metals basis
USP
Trimetoprim, United States Pharmacopeia (USP) Reference Standard
Supelco
Trimetoprim, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Óxido de titanio (IV), nanowires, diam. × L ~100 nm × 10 μm
Sigma-Aldrich
Titanium, foil, thickness 2.0 mm, 99.7% trace metals basis